Previous 10 | Next 10 |
Gainers: Greenland Technologies Corporation (NASDAQ:GTEC) +71%. Longeveron (NASDAQ:LGVN) +37%. Aurora (NASDAQ:AUR) +31%. Bakkt (NYSE:BKKT) +26%. FedNat Holding Company (NASDAQ:FNHC) +18%. UWM Holdings Corporation (NYSE:UWMC) +18%. SCYNEXIS (NASDAQ:SCYX) +16%. Kornit (NASDAQ:KRNT) +15%. Aspira...
Cassava Sciences is a company with a promising Alzheimer's Drug candidate. The FDA has a process called accelerated approval that allows for drugs to be approved for use before the finishing of drug trials. An accelerated approval would lead to a quick massive jump in the stock pr...
Cassava Sciences (NASDAQ:SAVA) has initiated a second Phase 3 study of simufilam, an investigational drug for patients with Alzheimer’s disease (AD). Shares up 3.5% premarket at $48.89. The study, called REFOCUS-ALZ is designed to evaluate the safety and efficacy of simu...
AUSTIN, Texas, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company, announced today it has initiated a second Phase 3 study of simufilam, the Company’s investigational drug for patients with Alzheimer’s disease. This second Phase 3 ...
Read the full story here: For further details see: Wall Street Breakfast: U.S. Targets High Oil Prices (Podcast by Pimm Fox)
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Tapping reserves The Biden administration is turning to some of the world's largest oil consuming nations to lower global prices after OPEC+ snubbed severa...
It takes the S&P 500 index on average around seven years to double. But plenty of stocks deliver 100% gains in a much shorter period of time. And some even triple or more. We asked three Motley Fool contributors to pick biotech stocks that have tripled or more so far this year. ...
Electric vehicles remained a central talking point among Wall Street traders on Wednesday. This came as Sono Motors (NASDAQ:SEV) spiked more than 150% in its debut as a public company, taking the spotlight from last week's darling, Rivian Automotive (NASDAQ:RIVN). Elsewhere, Ferrari (NYSE:RAC...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips This article is excerpted from Tom Yeung’s Moonshot Investor newsletter. To make sure you don’t miss any of Tom’s potential 100x picks, subscribe to his mailing list here . Inflationary Fears Rippl...
Shares of Cassava Sciences (NASDAQ: SAVA) , a clinical-stage biopharmaceutical company , plunged Wednesday after The Wall Street Journal published an article reporting that the Securities and Exchange Commission is investigating allegations about the company that surface...
News, Short Squeeze, Breakout and More Instantly...
Cassava Sciences, Inc. (NASDAQ: SAVA) is one of today's top gainers. The company's shares have moved 24.9% on the day to $12.59. Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.6% to $117.99 on volume of 383,510,118 shares Aptevo Therapeutics Inc. (APVO) rose 73.4% to $0.581 on volume of 315,289,581 shares PROSHARES TRUST (SQQQ) rose 8.7% to $8.11 on volume of 173,682,364 sha...